Author

Y. Hiramoto

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Organism:virus· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. Samadi· 1 shared C. Okumura· 1 shared J. K. Fleming· 1 shared K. C. Entzminger· 1 shared L. Y. Espinosa· 1 shared P. D. Entzminger· 1 shared T. Maruyama· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Samadi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintJan 25, 2023

Rapid engineering of SARS-CoV-2 therapeutic antibodies to increase breadth of neutralization including XBB.1.5 and BQ.1.1

K. C. Entzminger, J. K. Fleming, P. D. Entzminger…·T. Maruyama

This study engineers broadly neutralizing antibodies against SARS-CoV-2 variants using phage display and STEM technology, resulting in mAbs effective against XBB.1.5 and BQ.1.1.

DOI 10.1101/2023.01.25.525589

virusproteomics

𝕏 PostBluesky